Statistics

Total Visits

Views
A phase II trial of erlotinib as maintenance treatment after concurrent chemoradiotherapy in stage III non-small-cell lung cancer (NSCLC): a Galician Lung Cancer Group (GGCP) study.61

Select a period of time:

Number of views in the range

Views
A phase II trial of erlotinib as maintenance treatment after concurrent chemoradiotherapy in stage III non-small-cell lung cancer (NSCLC): a Galician Lung Cancer Group (GGCP) study.40

Views

Views
February 20254
March 202514
April 20252
May 20250
June 20253
July 202517
August 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore14
United States9
Brazil9
United Kingdom2
Kenya2
Spain2
Germany1
South Africa1
 

Top cities views

Views
Arlington Heights1
Cape Town1
Cedar Rapids1
Chattanooga1
Council Bluffs1
Coventry1
Munich1
Nairobi1
Pedra Preta1
Perryville1